 Cholesterol, LDL
"Cholesterol, LDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.
| Descriptor ID |
D008078
|
| MeSH Number(s) |
D04.210.500.247.808.197.244 D10.532.515.500 D10.570.938.208.275 D12.776.521.550.500
|
| Concept/Terms |
Cholesterol, LDL- Cholesterol, LDL
- Low Density Lipoprotein Cholesterol
- beta-Lipoprotein Cholesterol
- Cholesterol, beta-Lipoprotein
- beta Lipoprotein Cholesterol
- LDL Cholesterol
|
Below are MeSH descriptors whose meaning is more general than "Cholesterol, LDL".
Below are MeSH descriptors whose meaning is more specific than "Cholesterol, LDL".
This graph shows the total number of publications written about "Cholesterol, LDL" by people in this website by year, and whether "Cholesterol, LDL" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 2 | 2 | | 1992 | 0 | 1 | 1 | | 1993 | 1 | 1 | 2 | | 1995 | 1 | 1 | 2 | | 1996 | 0 | 4 | 4 | | 1998 | 0 | 3 | 3 | | 1999 | 2 | 3 | 5 | | 2000 | 0 | 4 | 4 | | 2001 | 0 | 3 | 3 | | 2002 | 3 | 0 | 3 | | 2003 | 1 | 5 | 6 | | 2004 | 0 | 3 | 3 | | 2005 | 3 | 10 | 13 | | 2006 | 6 | 4 | 10 | | 2007 | 4 | 6 | 10 | | 2008 | 3 | 6 | 9 | | 2009 | 3 | 3 | 6 | | 2010 | 1 | 6 | 7 | | 2011 | 3 | 7 | 10 | | 2012 | 5 | 10 | 15 | | 2013 | 3 | 8 | 11 | | 2014 | 8 | 9 | 17 | | 2015 | 2 | 7 | 9 | | 2016 | 4 | 7 | 11 | | 2017 | 2 | 6 | 8 | | 2018 | 2 | 5 | 7 | | 2019 | 2 | 12 | 14 | | 2020 | 5 | 10 | 15 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholesterol, LDL" by people in Profiles.
-
Piani F, Cicero AFG, Ventura F, Dormi A, Fogacci F, Patrono D, Mancini R, Ramazzotti E, Borghi C, D'Addato S. Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population. Int J Cardiol. 2021 05 01; 330:221-227.
-
Sabatine MS, Giugliano RP, Schwartz GG. Letter to the editor re: 'serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review'. Expert Rev Clin Pharmacol. 2021 02; 14(2):281-282.
-
Dixon DL, Saseen JJ. Pharmacist-administered long-acting injectable PCSK9 service: A solution to improve patient access and adherence. J Am Pharm Assoc (2003). 2021 May-Jun; 61(3):e83-e85.
-
Pirim D, Bunker CH, Hokanson JE, Hamman RF, Demirci FY, Kamboh MI. Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels. PLoS One. 2020; 15(12):e0243919.
-
Szarek M, Bittner VA, Aylward P, Baccara-Dinet M, Bhatt DL, Diaz R, Fras Z, Goodman SG, Halvorsen S, Harrington RA, Jukema JW, Moriarty PM, Pordy R, Ray KK, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG. Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial. Eur Heart J. 2020 11 21; 41(44):4245-4255.
-
Aramjoo H, Farkhondeh T, Aschner M, Naseri K, Mehrpour O, Sadighara P, Roshanravan B, Samarghandian S. The association between diazinon exposure and dyslipidemia occurrence: a systematic and meta-analysis study. Environ Sci Pollut Res Int. 2021 Jan; 28(4):3994-4006.
-
Piani F, Cicero AFG, Borghi C, D'Addato S. Is the 2020 Sampson equation the best formula for LDL-C estimation? Eur J Intern Med. 2021 01; 83:99-101.
-
Li X, Li Z, Zhou H, Gaynor SM, Liu Y, Chen H, Sun R, Dey R, Arnett DK, Aslibekyan S, Ballantyne CM, Bielak LF, Blangero J, Boerwinkle E, Bowden DW, Broome JG, Conomos MP, Correa A, Cupples LA, Curran JE, Freedman BI, Guo X, Hindy G, Irvin MR, Kardia SLR, Kathiresan S, Khan AT, Kooperberg CL, Laurie CC, Liu XS, Mahaney MC, Manichaikul AW, Martin LW, Mathias RA, McGarvey ST, Mitchell BD, Montasser ME, Moore JE, Morrison AC, O'Connell JR, Palmer ND, Pampana A, Peralta JM, Peyser PA, Psaty BM, Redline S, Rice KM, Rich SS, Smith JA, Tiwari HK, Tsai MY, Vasan RS, Wang FF, Weeks DE, Weng Z, Wilson JG, Yanek LR, Neale BM, Sunyaev SR, Abecasis GR, Rotter JI, Willer CJ, Peloso GM, Natarajan P, Lin X. Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale. Nat Genet. 2020 09; 52(9):969-983.
-
Szarek M, Amarenco P, Callahan A, Goldstein LB, Sillesen H, Welch KM. Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. J Am Coll Cardiol. 2020 08 18; 76(7):886-888.
-
Bonaca MP, Hess CN. ASCVD Risk and Statin Use in PAD: Implementing a New Approach to an Old Problem. J Am Coll Cardiol. 2020 07 21; 76(3):265-267.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|